MAOA/HSP90-IN-1 is a dual inhibitor of MAO A and HSP90, used in the research of brain tumor-related diseases; it suppresses malignant glioblastoma (GBM) by inhibiting MAO A activity, HSP90 binding, and the expression of HER2 and phospho-Akt; it also reduces PD-L1 expression, which suppresses T-cell activation, demonstrating potential in inhibiting tumor immune evasion.